The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 01, 2017

Filed:

Oct. 31, 2012
Applicant:

Shanghai RI Xin Biotechnolgy Co., Ltd., Shanghai, CN;

Inventors:

Chunjiu Zhong, Shanghai, CN;

Yinhua He, Shanghai, CN;

Xuefeng Mei, Shanghai, CN;

Huan Zhang, Shanghai, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/165 (2006.01); A61K 31/565 (2006.01); A61K 31/557 (2006.01); A61K 31/519 (2006.01); A61K 31/19 (2006.01); A61K 45/06 (2006.01); C07D 487/04 (2006.01); C07D 487/14 (2006.01); C07F 9/6512 (2006.01);
U.S. Cl.
CPC ...
C07F 9/65127 (2013.01);
Abstract

The present invention is directed to crystalline polymorphs of benfotiamine, its methods of preparation and its use thereof. Five crystalline polymorphs of benfotiamine are designated as crystalline forms A, B, C, D and E, and may be distinguished by their respective patterns of X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), infrared spectroscopy (IR), raman spectroscopy, moreover by their diverse preparing process. The crystalline polymorphs of the present invention are useful as they act in treating Vitamin B1 deficiency, metabolic disorders, mental illness and disorders, diabetes complications, neurodegerative diseases. Further the present invention is a process for preparing and transforming diverse crystalline form of benfotiamine through different synthesis routes and varied solvents and combinations. The crystalline polymorphs of the present invention are basically pure. The present invention not only provides new crystalline forms of benfotiamine, but also provides its new solvates, especially hydrates.


Find Patent Forward Citations

Loading…